Ospedale Niguarda

Running trials

• Not yet recruiting

  Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

  NCT07746232· Source

• Recruiting

  Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

  NCT06994377· Source

• Recruiting

  Italian Anderson Fabry Disease Cardiovascular Registry

  NCT06806813· Source

• Active, not recruiting

  Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

  NCT04704934· Phase 3· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Source

• Active, not recruiting

  Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

  NCT04041310· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fabry disease1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  Melflufen for Elderly Patients With Relapsed Myeloma

  NCT06682637· Phase 2· Source